Literature DB >> 27382095

Evolving Role of the Estrogen Receptor as a Predictive Biomarker: ESR1 Mutational Status and Endocrine Resistance in Breast Cancer.

Josh Lauring1, Antonio C Wolff2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27382095     DOI： 10.1200/JCO.2016.68.4720

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer.

Authors:  Lorenzo Gerratana; Debora Basile; Alessandra Franzoni; Lorenzo Allegri; Davide Viotto; Carla Corvaja; Lucia Bortot; Elisa Bertoli; Silvia Buriolla; Giada Targato; Lucia Da Ros; Stefania Russo; Marta Bonotto; Barbara Belletti; Gustavo Baldassarre; Giuseppe Damante; Fabio Puglisi
Journal:  Front Oncol       Date:  2020-09-18       Impact factor: 6.244

2.  Cytotoxicity anticancer activities of anastrozole against breast, liver hepatocellular, and prostate cancer cells.

Authors:  Firas Hassan; Gamal A El-Hiti; Mays Abd-Allateef; Emad Yousif
Journal:  Saudi Med J       Date:  2017-04       Impact factor: 1.484

Review 3.  Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast Cancer.

Authors:  Tomas Reinert; Everardo D Saad; Carlos H Barrios; José Bines
Journal:  Front Oncol       Date:  2017-03-15       Impact factor: 6.244

4.  Methylation-to-Expression Feature Models of Breast Cancer Accurately Predict Overall Survival, Distant-Recurrence Free Survival, and Pathologic Complete Response in Multiple Cohorts.

Authors:  Jeffrey A Thompson; Brock C Christensen; Carmen J Marsit
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.